Abano Healthcare Group LtdABA:NZC

7.40
0.04 / 0.54%
21.47k
23.33%
0.4361
Close in NZDToday's changeShares traded1 year changeBeta
Data delayed at least 60 minutes, as of Dec 19 2014 03:59 GMT.

Summary

Abano Healthcare Group Ltd (ABA:NZC) set a new 52-week high during Friday's trading session when it reached 7.45. Over this period, the share price is up 16.17%.

52-week range
Today
5.90
Feb 04 2014
7.45
Dec 19 2014
Markit short selling activity
Low
Medium
High
Open7.45
Day high7.45
Day low7.40
Bid7.40
Offer7.45
Previous close7.44
Average volume4.08k
Shares outstanding20.75m
Free float15.33m
P/E (TTM)29.62
Market cap153.57m NZD
EPS (TTM)0.2498 NZD
Annual div (TTM)0.21 NZD
Annual div yield (TTM)2.84%
Div ex-dateAug 07 2014
Div pay-dateAug 21 2014
Data delayed at least 60 minutes, as of Dec 19 2014 03:59 GMT.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Abano Healthcare Group Ltd+1.23%+2.78%+11.28%+23.33%-8.26%
NEW ZEALAND EXCH NZSX 50 FREE IDX+0.23%+0.10%+7.44%+17.44%+75.25%
NZ/HEALTH CARE+0.85%+1.70%-2.67%+4.85%--
NZ/H CARE PROV & SVC+0.85%+1.70%-2.67%+4.85%--
Data delayed at least 60 minutes, as of Dec 19 2014 03:59 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.